Dr. Cynthia Gilmour, FNP
What this data tells you about Dr. Gilmour
Dr. Cynthia Gilmour is a nurse practitioner - family in Bonita Springs, FL, with 19 years of NPI registration. Based on federal Medicare data, Dr. Gilmour performed 7,114 Medicare services across 4,890 unique beneficiaries.
Between the years covered by Open Payments, Dr. Gilmour received a total of $482 from 14 pharmaceutical and/or device companies across 20 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in nurse practitioner - family. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Gilmour is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
Florida License Status
FL DOH · MQA| Profession | License # | Status | Expires | Board Action |
|---|---|---|---|---|
| Advanced Practice Registered Nurse | 11037233 | Clear | July 31, 2026 | — |
Medicare Practice Summary
Medicare Utilization ↗Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) | 758 | $82 | $141 |
| Blood draw (venipuncture) | 728 | $7 | $8 |
| Complete blood count (CBC) with differential | 637 | $8 | $8 |
| Comprehensive metabolic blood panel | 517 | $10 | $11 |
| Lipid panel (cholesterol and triglycerides) | 491 | $13 | $14 |
| Urinalysis, manual | 474 | $3 | $4 |
| Vitamin D level test | 349 | $29 | $30 |
| Office visit, established patient (20-29 min) | 267 | $56 | $101 |
| Hemoglobin A1c test (diabetes monitoring) | 227 | $9 | $10 |
| Electrocardiogram (EKG), 12-lead | 195 | $9 | $17 |
| Thyroid stimulating hormone (TSH) test | 192 | $16 | $17 |
| Thyroxine (thyroid chemical), total | 172 | $7 | $7 |
| Thyroid hormone evaluation | 172 | $6 | $7 |
| Detection test by immunoassay with direct visual observation for severe acute respiratory syndrome coronavirus 2 (covid-19) | 138 | $41 | $59 |
| Blood test, basic group of blood chemicals (calcium, ionized) | 104 | $13 | $15 |
| Flu vaccine administration | 103 | $29 | $30 |
| Detection test by nucleic acid for multiple types influenza virus | 95 | $94 | $97 |
| Urine microalbumin (protein) analysis | 92 | $6 | $6 |
| Creatinine test (kidney function) | 87 | $5 | $10 |
| Amplifed dna or rna probe detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antigen | 79 | $50 | $51 |
| Detection test by nucleic acid for strep (streptococcus, group a), amplified probe technique | 79 | $34 | $36 |
| Analysis for antibody borrelia burgdorferi (lyme disease bacteria) | 71 | $17 | $17 |
| Annual wellness visit, follow-up | 70 | $117 | $142 |
| Vitamin B-12 level test | 59 | $15 | $16 |
| Injection, ketorolac tromethamine, per 15 mg | 58 | $0 | $1 |
| Flu vaccine, high-dose | 49 | $72 | $73 |
| Advance care planning consultation, first 30 min | 49 | $67 | $93 |
| Flu vaccine, quadrivalent | 48 | $73 | $74 |
| Drug injection, under skin or into muscle | 45 | $9 | $15 |
| New patient office visit (45-59 min) | 45 | $118 | $182 |
| PSA test (prostate cancer screening) | 44 | $18 | $20 |
| Creatine kinase (cardiac enzyme) level, total | 38 | $6 | $7 |
| Creatine kinase (cardiac enzyme) level, mb fraction only | 36 | $11 | $12 |
| Myoglobin (muscle protein) level | 36 | $12 | $14 |
| Troponin (protein) analysis, quantitative | 36 | $12 | $13 |
| Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 34 | $74 | $75 |
| Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within | 34 | $24 | $25 |
| Iron level test | 32 | $6 | $7 |
| Iron binding capacity test | 32 | $9 | $10 |
| Magnesium level test | 32 | $7 | $7 |
| Lactate dehydrogenase (enzyme) level | 31 | $6 | $6 |
| Glutamyltransferase (liver enzyme) level | 29 | $7 | $7 |
| Prostate cancer screening; prostate specific antigen test (psa) | 28 | $19 | $19 |
| New patient office visit (30-44 min) | 26 | $68 | $127 |
| Smoking and tobacco use intensive counseling, 4-10 minutes | 26 | $13 | $16 |
| Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | 25 | $282 | $294 |
| Pneumonia vaccine administration | 23 | $30 | $30 |
| Parathyroid hormone level test | 22 | $40 | $41 |
| Folic acid level test | 19 | $14 | $17 |
| Detection test by nucleic acid for respiratory syncytial virus, amplified probe technique | 19 | $69 | $70 |
| Natriuretic peptide (heart and blood vessel protein) level | 18 | $38 | $39 |
| Red blood cell sedimentation rate, to detect inflammation, non-automated | 17 | $4 | $5 |
| Injection, methylprednisolone sodium succinate, up to 125 mg | 15 | $4 | $5 |
| Telephone medical discussion with physician, 5-10 minutes | 12 | $37 | $61 |
Industry Payment Transparency
Open Payments through 2024 ↗Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
Payments by company (2024)
Associated products mentioned in payments ›
Most payments (80%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
7.3 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Gilmour is a clinical cardiology specialist, with above-average Medicare volume (top 1% in FL), with low-engagement industry engagement, with 19 years of NPI registration.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Gilmour experienced with office visit, established patient (30-39 min)?
Does Dr. Gilmour receive payments from pharmaceutical companies?
How do Dr. Gilmour's costs compare to other family nurse practitioners in Bonita Springs?
What does Data Coverage mean?
Is this data up to date?
Explore related providers
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology